Concurrent occurrence of Amp C and Cefotaxime (CTX)-M inclinical isolates of enterobacteriaceae
Diji Sara Varghese, Uma Sekar, Mariappan Shanthi, Kamalanathan Arunagiri, Arun Vishwanathan, VM Vidhya, Balaraman Sekar
Keywords :
CTX-M, enterobacteriaceae, plasmid Amp C
Citation Information :
Varghese DS, Sekar U, Shanthi M, Arunagiri K, Vishwanathan A, Vidhya V, Sekar B. Concurrent occurrence of Amp C and Cefotaxime (CTX)-M inclinical isolates of enterobacteriaceae. 2014; 16 (1):11-16.
Enterobacteriaceae producing both Amp C beta lactamases and extended-spectrum beta lactamases (ESBLs) have been increasingly reported worldwide. While the phenotypic tests for ESBL is standardised and used widely, it is not so for Amp C. When they coexist they may mask each other's detection phenotypically. We undertook this study to detect the concurrent occurrence of Cefotaxime (CTX)-M and plasmid Amp C in clinical isolates of Enterobacteriaceae by phenotypic and genotypic methods. One hundred clinically significant isolates of Escherichia coli (E. coli; 43), Klebsiella pneumoniae (K. pneumoniae; 43) and Proteus mirabilis (P. mirabilis; 14) were included in the study. Antibiotic susceptibility testing to various classes of antimicrobials was performed by disc diffusion using Clinical Laboratory Standards Institute (CLSI) guidelines. Isolates were screened for production of ESBL by CLSI method and Amp C beta lactamase by inhibitor based method using boronic acid and cloxacillin. Polymerase chain reaction (PCR) was performed for the detection of plasmid Amp C genes and blaCTX-M. Plasmid Amp C genes were detected in 27 isolates which included CIT (Origin Citrobacter freundii): 14; DHA (Dhahran Hospital in Saudi Arabia): 12; EBC (Origin Enterobacter cloacae): 1. BlaCTX-M was detected in 51 isolates. Both coexisted in one E. coli and two K. pneumoniae. In one of the K. pneumoniae isolate, all phenotypic tests employed were negative. A high degree of cross resistance to other classes of antimicrobials was observed. Carbapenem resistance was noted in 21 isolates. The concurrent occurrence of Amp C and CTX-M is not common in clinical isolates of Enterobacteriaceae. Phenotypic tests perform poorly when these enzymes are coproduced.
Bush K, Fisher JF. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol 2011;65:455-78.
Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14 Suppl 1:159-65.
Shahid M, Sobia F, Singh A, Khan HM. Concurrent occurrence of blaamp C -families, blaCTX-M -genogroups and association with mobile genetic elements ISEcp1, IS26, ISCR1, and sul-1-type class 1 integrons in Escherichia coli and Klebsiella pneumoniae originating from India. J Clin Microbiol 2012;50:1779-82.
Singh RK, Pal NK, Banerjee M, Sarkar S, Sengupta M. Surveillance on extended spectrum β-lactamase and Amp C β-lactamase producing gram negative isolates from nosocomial infections. Arch Clin Microbiol 2012;3.
Sinha P, Sharma R, Rishi S, Sharma R, Sood S, Pathak D. Prevalence of extended spectrum beta lactamase and Amp C beta lactamase producers among Escherichia coli isolates in a tertiary care hospital in Jaipur. Indian J Pathol Microbiol 2008;51:367-9.
Clinical Laboratory Standards Institute. Performance standards for Antimicrobial Susceptibility Testing: Twenty first Informational Supplement. CLSI document M100-S21. Wayne: Clinical and Laboratory Standards Institute; 2011.
Tan TY, Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid- mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother 2009;53:146-9.
Perez-Perez FJ, Hanson ND. Detection of plasmid - mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40:2153-62.
Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals. Antimicrob Agents Chemother 2003;47:3724-32.
Thomson KS. Extended spectrum-beta-lactamases, Amp C and Carbapenamase issues. J Clin Microbiol 2010;48:1019-25.
Mohamudha PR, Harish BN, Parija SC. Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in India. Indian J Med Res 2012;135:114-9.
Shanthi M, Sekar U, Arunagiri K, Sekar B. Detection of Amp C genes encoding for beta-lactamases in Escherichia coli and Klebsiella pneumoniae. Indian J Med Microbiol 2012;30:290-5.
Upadhyay S, Sen MR, Bhattacharjee A. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing Amp C β-lactamases. J Med Microbiol 2011;60:691-3.
Koh TH, Wang GC, Sng LH, Yi Z, Koh TY. CTX-M and plasmid-mediated Amp C-producing Enterobacteriaceae Singapore. Emerg Infect Dis 2004;10:1172-4.
Park YJ, Lee S, Kim YR, Oh EJ, Woo GJ, Lee K. Occurrence of extended spectrumβ lactamases and plasmid mediated Amp C (beta)-lactamases among Korean isolates of Proteus mirabilis. J Antimicrob Chemother 2006;57:156-8.
Song W, Lee H, Lee K, Jeong SH, Bae IK, Kim JS, et al. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 2009;58:261-6.
Kingsley J, Verghese S. Sequence analysis of bla CTX-M-28, an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India. Indian J Pathol Microbiol 2008;51:218-21.
Jemima SA, Verghese S. Multiplex PCR for (blaCTX-M) & bla (SHV) in the extended spectrum beta lactamase (ESBL) producing gram-negative isolates. Indian J Med Res 2008;128:313-7.
Baby Padmini S, Appala Raju B, Mani KR. Detection of Enterobacteriaceae producing CTX-M extended spectrum beta-lactamases from a tertiary care hospital in South India. Indian J Med Microbiol 2008;26:163-6.
